EyePoint Inc
EyePoint Inc (EYPT) Historical Volatility
EYPT's 30 day historical volatility is 557.28%, in the 94th percentile of readings over the past year. This is a high percentile, meaning EyePoint Inc shares have swung far more than usual. EYPT's 30 day implied volatility sits at 319.91%, with an IV Rank of 84.92%, leaving IV 237.37 points below historical volatility. This means options are pricing in less movement than the stock has actually delivered, as of Nov 18, 2026.
Read more
Tracking EYPT historical volatility helps you see how much EyePoint Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, EYPT's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor EYPT 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. EYPT's 30 day historical volatility, or EYPT HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing EYPT's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye; and DEXYCU, a dexamethasone intraocular suspension, for the treatment of post-operative ocular inflammation, including treatment following cataract surgery.
Historical Volatility
Historical movement is elevated versus the past year. The stock has been unusually active.
As of Nov 18, 2026
As of Nov 18, 2026
As of Nov 18, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →